Imaging risk in pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a Janus-faced entity with, on one side, the pulmonary circulation and, on the other side, the right ventricle (RV) [1]. While the disease process is turned on at the site of the pulmonary resistive vessels, the patient symptomatology and prognosis are largely determined by RV structure and function adaptation to increased afterload [2, 3]. Yet, this important cardiac aspect of PAH pathophysiology remains insufficiently recognised. The study by Ghio et al. [4], in the present issue of the European Respiratory Journal, is therefore a welcome step forward.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Editorials Source Type: research